Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint - PubMed (original) (raw)
Comparative Study
Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint
J S Johansen et al. Br J Rheumatol. 1996 Jun.
Abstract
YKL-40 is a recently discovered human glycoprotein which is related in amino acid sequence to the chitinase protein family. YKL-40 is a major secretory protein of human chondrocytes and synoviocytes, and could play a role in tissue remodelling. The aim of the study was to establish the serum YKL-40 level in normal subjects and to evaluate serum YKL-40 as a marker for osteoarthritis. Serum YKL-40 was 80 micrograms/l in healthy children (n = 476) and 102 micrograms/l in healthy adults (n = 260). No age or sex differences were found in serum YKL-40 in subjects younger than 70 yr, but thereafter serum YKL-40 increased significantly. Patients with late-stage osteoarthritis of the knee (n = 37) had significantly higher serum YKL-40 (1.5-fold; P < 0.01) compared to healthy age-matched subjects, whereas patients with early-stage osteoarthritis of the knee or recent torn cruciate ligaments or menisci did not have elevated serum YKL-40. The level of YKL-40 in serum and synovial fluid correlated significantly, and 10-fold higher values were found in synovial fluid. YKL-40 levels in serum and synovial fluid of patients with acute severe synovial inflammation were significantly higher (P < 0.05-P < 0.001) than those in patients with no, light or moderate synovitis of the knee joint. Furthermore, YKL-40 correlated significantly (P < 0.01) with the amino-terminal propeptide of type III procollagen, but not with serum C-reactive protein. Our data indicate that YKL-40 in synovial fluid and serum may reflect human articular cartilage degradation and the degree of synovial inflammation in the knee joint.
Similar articles
- Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.
Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, Ostergaard K, Løvgreen-Nielsen P, Sonne-Holm S, Lorenzen I. Volck B, et al. Osteoarthritis Cartilage. 2001 Apr;9(3):203-14. doi: 10.1053/joca.2000.0377. Osteoarthritis Cartilage. 2001. PMID: 11300743 - A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid.
Johansen JS, Jensen HS, Price PA. Johansen JS, et al. Br J Rheumatol. 1993 Nov;32(11):949-55. doi: 10.1093/rheumatology/32.11.949. Br J Rheumatol. 1993. PMID: 8220933 - Increased Synovial Fluid YKL-40 Levels are Linked with Symptomatic Severity in Knee Osteoarthritis Patients.
Guan J, Liu Z, Li F, Feng JS, Wang HJ, Chu JG, Song YZ, Xie L, Ding LB. Guan J, et al. Clin Lab. 2015;61(8):991-7. doi: 10.7754/clin.lab.2015.150135. Clin Lab. 2015. PMID: 26427144 - [YKL 40: marker of disease activity in rheumatoid arthritis?].
Morgante M, Di Munno O, Morgante D. Morgante M, et al. Minerva Med. 1999 Nov-Dec;90(11-12):437-41. Minerva Med. 1999. PMID: 10829806 Review. Italian. - YKL-40: a potential biomarker for osteoarthritis.
Huang K, Wu LD. Huang K, et al. J Int Med Res. 2009 Jan-Feb;37(1):18-24. doi: 10.1177/147323000903700102. J Int Med Res. 2009. PMID: 19215669 Review.
Cited by
- Obesity modulates the association between sleep apnea treatment and CHI3L1 levels but not CHIT1 activity in moderate to severe OSA: an observational study.
Teitsdottir UD, Arnardottir ES, Bjornsdottir E, Gislason T, Petersen PH. Teitsdottir UD, et al. Sleep Breath. 2018 Dec;22(4):1101-1109. doi: 10.1007/s11325-018-1731-6. Epub 2018 Oct 11. Sleep Breath. 2018. PMID: 30311184 Free PMC article. - Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis.
Jafari-Nakhjavani MR, Ghorbanihaghjo A, Bagherzadeh-Nobari B, Malek-Mahdavi A, Rashtchizadeh N. Jafari-Nakhjavani MR, et al. Caspian J Intern Med. 2019 Winter;10(1):92-97. doi: 10.22088/cjim.10.1.92. Caspian J Intern Med. 2019. PMID: 30858947 Free PMC article. - Republished: Value of biomarkers in osteoarthritis: current status and perspectives.
Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyère O, Chapurlat R, Collette J, Cooper C, Giacovelli G, Kanis JA, Karsdal MA, Kraus V, Lems WF, Meulenbelt I, Pelletier JP, Raynauld JP, Reiter-Niesert S, Rizzoli R, Sandell LJ, Van Spil WE, Reginster JY. Lotz M, et al. Postgrad Med J. 2014 Mar;90(1061):171-8. doi: 10.1136/postgradmedj-2013-203726rep. Postgrad Med J. 2014. PMID: 24534711 Free PMC article. - High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality.
Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H. Johansen JS, et al. Clin Exp Immunol. 2008 Feb;151(2):260-6. doi: 10.1111/j.1365-2249.2007.03561.x. Epub 2007 Dec 6. Clin Exp Immunol. 2008. PMID: 18070151 Free PMC article. - Investigation of generalized osteoarthritis by combining X-ray grading of the knee, spine and hand using biochemical markers for arthritis in patients with knee osteoarthritis.
Abe M, Takahashi M, Naitou K, Ohmura K, Nagano A. Abe M, et al. Clin Rheumatol. 2003 Dec;22(6):425-31. doi: 10.1007/s10067-003-0802-6. Epub 2003 Nov 13. Clin Rheumatol. 2003. PMID: 14677020
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials